Y-Biologics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	38,922	9,083	20,535	12,614	16,873
Short-Term Investments	3,031	3,000	362.11	368.9	74.96
Trading Asset Securities	2,316	120.49	-	-	-
Cash & Short-Term Investments	44,269	12,204	20,898	12,983	16,948
Cash Growth	262.75%	-41.60%	60.97%	-23.40%	-49.24%
Accounts Receivable	25.96	63.87	573.37	689.88	825.19
Other Receivables	238.41	27.78	21.97	0.67	317.93
Receivables	264.37	91.64	595.34	690.55	1,143
Prepaid Expenses	50.44	42.91	89.29	20.2	91.4
Other Current Assets	231.05	132.56	180.33	845.17	1,663
Total Current Assets	44,815	12,471	21,763	14,538	19,845
Property, Plant & Equipment	6,899	7,407	8,009	10,801	16,824
Long-Term Investments	2,049	89.03	-	-	-
Other Intangible Assets	530.88	223.37	247.18	316.56	279.35
Other Long-Term Assets	1,504	1,538	275.5	3,667	1,296
Total Assets	55,798	21,727	30,294	29,323	38,245
Accounts Payable	0.27	3.23	1.21	-	-
Accrued Expenses	214.41	243.31	205.33	224.38	352.99
Short-Term Debt	65	-	2,000	-	-
Current Portion of Long-Term Debt	-	500	-	4,528	2,336
Current Portion of Leases	181	153.57	192.47	223.39	516.5
Other Current Liabilities	778.63	262	508.83	3,569	3,003
Total Current Liabilities	1,239	1,162	2,908	8,545	6,209
Long-Term Debt	14,366	-	500	-	2,528
Long-Term Leases	141.13	125.19	200.01	188.1	574.62
Other Long-Term Liabilities	13,454	802.45	677.72	645.96	491.76
Total Liabilities	29,200	2,090	4,286	9,379	9,803
Common Stock	7,589	7,391	7,381	6,145	6,141
Additional Paid-In Capital	176,041	124,295	122,727	93,385	93,287
Retained Earnings	-162,315	-120,290	-113,849	-92,978	-74,173
Comprehensive Income & Other	5,283	6,960	7,149	5,741	3,186
Total Common Equity	26,597	18,356	23,408	12,293	28,441
Shareholders' Equity	26,597	19,637	26,008	19,943	28,441
Total Liabilities & Equity	55,798	21,727	30,294	29,323	38,245
Total Debt	14,753	778.76	2,892	4,940	5,955
Net Cash (Debt)	29,516	11,425	18,005	8,043	10,992
Net Cash Growth	158.35%	-36.55%	123.86%	-26.83%	-60.80%
Net Cash Per Share	1982.01	773.28	1438.30	654.40	903.42
Filing Date Shares Outstanding	14.98	14.78	14.76	12.29	12.17
Total Common Shares Outstanding	14.98	14.78	14.76	12.29	12.17
Working Capital	43,575	11,309	18,855	5,993	13,636
Book Value Per Share	1775.21	1241.72	1585.65	1000.22	2337.50
Tangible Book Value	26,066	18,132	23,161	11,977	28,162
Tangible Book Value Per Share	1739.78	1226.61	1568.90	974.46	2314.54
Land	749.16	749.16	594.79	594.79	594.79
Buildings	4,326	4,326	3,370	3,370	3,370
Machinery	10,781	10,580	10,479	12,144	11,635
Construction In Progress	340.51	317.23	377.82	301.48	3,703

Source: S&P Global Market Intelligence. Standard template. Financial Sources.